serw-MX  [xml]  
 
    
 DeCS Categories

C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities .
C16.320 Genetic Diseases, Inborn .
C16.320.565 Metabolism, Inborn Errors .
C16.320.565.398 Lipid Metabolism, Inborn Errors .
C16.320.565.398.641 Lipidoses .
C18 Nutritional and Metabolic Diseases .
C18.452 Metabolic Diseases .
C18.452.584 Lipid Metabolism Disorders .
C18.452.584.500 Dyslipidemias .
C18.452.584.500.500 Hyperlipidemias .
C18.452.584.687 Lipidoses .
C18.452.648 Metabolism, Inborn Errors .
C18.452.648.398 Lipid Metabolism, Inborn Errors .
C18.452.648.398.641 Lipidoses .
D02 Organic Chemicals .
D02.241 Carboxylic Acids .
D02.241.081 Acids, Acyclic .
D02.241.081.114 Butyrates .
D02.241.081.114.968 Isobutyrates .
D02.241.081.114.968.500 Fibric Acids .
D02.241.081.114.968.500.625 Fenofibrate .
D02.355 Ethers .
D02.355.726 Phenyl Ethers .
D02.355.726.305 Fibric Acids .
D02.355.726.305.625 Fenofibrate .
D02.455 Hydrocarbons .
D02.455.426 Hydrocarbons, Cyclic .
D02.455.426.559 Hydrocarbons, Aromatic .
D02.455.426.559.389 Benzene Derivatives .
D02.455.426.559.389.134 Benzophenones .
D02.455.426.559.389.134.750 Fenofibrate .
D02.455.426.559.389.657 Phenols .
D02.455.426.559.389.657.654 Phenyl Ethers .
D02.455.426.559.389.657.654.305 Fibric Acids .
D02.455.426.559.389.657.654.305.625 Fenofibrate .
D02.522 Ketones .
D02.522.223 Benzophenones .
D02.522.223.750 Fenofibrate .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.129 Azoles .
D03.383.129.578 Pyrroles .
D03.383.129.578.075 Atorvastatin Calcium .
D09 Carbohydrates .
D09.698 Polysaccharides .
D09.698.718 Polysaccharides, Bacterial .
D09.698.718.450 Lipopolysaccharides .
D09.698.718.450.500 Lipid A .
D10 Lipids .
D10.251 Fatty Acids .
D10.251.450 Heptanoic Acids .
D10.251.450.200 Atorvastatin Calcium .
D10.494 Lipopolysaccharides .
D10.494.500 Lipid A .
D23 Biological Factors .
D23.050 Antigens .
D23.050.161 Antigens, Bacterial .
D23.050.161.616 Polysaccharides, Bacterial .
D23.050.161.616.525 Lipopolysaccharides .
D23.050.161.616.525.500 Lipid A .
D23.946 Toxins, Biological .
D23.946.123 Bacterial Toxins .
D23.946.123.329 Endotoxins .
D23.946.123.329.500 Lipopolysaccharides .
D23.946.123.329.500.500 Lipid A .
 
 Terms
 Synonyms & Historicals		Documents
LILACS e MDL		 
Fenofibrate .
Antara Micronized Procetofen .
Apo-Feno-Micro .
Apo-Fenofibrate .
CiL 8694 .
Controlip .
Fenobeta .
Fenofanton .
Fenofibrat AL .
Fenofibrat AZU .
Fenofibrat AbZ .
Fenofibrat FPh .
Fenofibrat Heumann .
Fenofibrat Hexal .
Fenofibrat Stada .
Fenofibrat-ratiopharm .
Fénofibrate Debat .
Fénofibrate MSD .
Gen-Fenofibrate .
LF-178 .
Lipanthyl .
Lipantil .
Liparison .
Lipidil .
Lipidil-Ter .
Livesan .
Lofibra .
MTW-Fenofibrat .
Normalip .
Novo-Fenofibrate .
Nu-Fenofibrate .
PMS-Fenofibrate Micro .
Phenofibrate .
Procetofene .
Secalip .
Supralip .
Tricor .
durafenat .
fenofibrat von ct .
AZU, Fenofibrat .
Apo Feno Micro .
Apo Fenofibrate .
Debat, Fénofibrate .
Fenofibrat ratiopharm .
Gen Fenofibrate .
Heumann, Fenofibrat .
Hexal, Fenofibrat .
LF 178 .
LF178 .
Lipidil Ter .
MTW Fenofibrat .
Micronized Procetofen, Antara .
Novo Fenofibrate .
Nu Fenofibrate .
PMS Fenofibrate Micro .
Procetofen, Antara Micronized .
Stada, Fenofibrat .
Procetofen .
LIPANTHYL .
An antilipemic agent which reduces both CHOLESTEROL and TRIGLYCERIDES in the blood. .
1.00
92393
 
Lipids .
Lipids and Antilipemic Agents .
A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) .
0.66
142894231
 
Lipid A .
Lipid A is the biologically active component of lipopolysaccharides. It shows strong endotoxic activity and exhibits immunogenic properties. .
0.58
33424
 
Hyperlipidemias .
Hyperlipidemia .
Lipemia .
Lipidemia .
Hyperlipemias .
Lipemias .
Lipidemias .
Hyperlipemia .
Conditions with excess LIPIDS in the blood. .
0.57
70124372
 
Lipidoses .
Lipoidosis .
Lipidosis .
Lipoidoses .
Conditions characterized by abnormal lipid deposition due to disturbance in lipid metabolism, such as hereditary diseases involving lysosomal enzymes required for lipid breakdown. They are classified either by the enzyme defect or by the type of lipid involved. .
0.57
182576
 
Atorvastatin Calcium .
Atorvastatin .
Atorvastatin Calcium Anhydrous .
Atorvastatin Calcium Hydrate .
Atorvastatin Calcium Trihydrate .
Atorvastatin, Calcium Salt .
CI 981 .
CI-981 .
Lipitor .
Liptonorm .
Anhydrous, Atorvastatin Calcium .
CI981 .
Calcium Anhydrous, Atorvastatin .
Calcium Hydrate, Atorvastatin .
Calcium Salt Atorvastatin .
Calcium Trihydrate, Atorvastatin .
Calcium, Atorvastatin .
Hydrate, Atorvastatin Calcium .
Trihydrate, Atorvastatin Calcium .
A pyrrole and heptanoic acid derivative,HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; AND TRIGLYCERIDES and to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS and prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors. .
0.54
225755